Based on expression ranges of normal tissues, 30 (30%) and 16 (16%) of 100 primary tumors were classified as abnormally low and high Cav-1 expressors, respectively and 6 (42.9%) and 6 (42.9%) of 14 cancer cell lines were classified as abnormally low and high expressors, respectively. This evidence concerns the gene CAV1 and cancer.